Artificial tears are lubricating eye drops used to relieve dryness and irritation in the eyes. They are composed of water, salts, and polymers designed to mimic the natural composition of tears, providing moisture and comfort to the eyes. In ophthalmology, artificial tears are crucial in managing dry eye syndrome, a condition where the eyes do not produce enough tears or the tears evaporate too quickly. Symptoms include stinging or burning sensations, redness, sensitivity to light, and blurred vision. Different formulations cater to varying severities of dry eye, from mild discomfort to chronic conditions requiring frequent application. Some artificial tears contain preservatives to prolong shelf life, while preservative-free options are gentler for those with sensitive eyes. Proper selection of artificial tears depends on the individual's symptoms and the underlying cause of dry eye syndrome, making them a versatile tool in ophthalmic care.
Purpose: To determine the efficacy of the daily artificial tears usage as a dry eye syndrome prophylaxis among medical students, who are at increased risk due to lifestyle factors. Methods: We…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Artificial Tears work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Artificial Tears research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Artificial Tears track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Artificial Tears. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Artificial Tears are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Artificial Tears track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
